178 related articles for article (PubMed ID: 33841104)
1. The Effect of GLT-1 Upregulation on Extracellular Glutamate Dynamics.
Wilkie CM; Barron JC; Brymer KJ; Barnes JR; Nafar F; Parsons MP
Front Cell Neurosci; 2021; 15():661412. PubMed ID: 33841104
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal Synaptic Dysfunction in a Mouse Model of Huntington Disease Is Not Alleviated by Ceftriaxone Treatment.
Wilkie CM; Barnes JR; Benson CM; Brymer KJ; Nafar F; Parsons MP
eNeuro; 2020; 7(3):. PubMed ID: 32354757
[TBL] [Abstract][Full Text] [Related]
3. Region- and Activity-Dependent Regulation of Extracellular Glutamate.
Pinky NF; Wilkie CM; Barnes JR; Parsons MP
J Neurosci; 2018 Jun; 38(23):5351-5366. PubMed ID: 29760178
[TBL] [Abstract][Full Text] [Related]
4. Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression.
LaCrosse AL; O'Donovan SM; Sepulveda-Orengo MT; McCullumsmith RE; Reissner KJ; Schwendt M; Knackstedt LA
J Neurosci; 2017 Jun; 37(24):5809-5821. PubMed ID: 28495973
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat.
Goodrich GS; Kabakov AY; Hameed MQ; Dhamne SC; Rosenberg PA; Rotenberg A
J Neurotrauma; 2013 Aug; 30(16):1434-41. PubMed ID: 23510201
[TBL] [Abstract][Full Text] [Related]
6. GLT-1 Knockdown Inhibits Ceftriaxone-Mediated Improvements on Cognitive Deficits, and GLT-1 and xCT Expression and Activity in APP/PS1 AD Mice.
Gao J; Liu L; Liu C; Fan S; Liu L; Liu S; Xian XH; Li WB
Front Aging Neurosci; 2020; 12():580772. PubMed ID: 33132901
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone-mediated upregulation of the glutamate transporter GLT-1 contrasts neurotoxicity evoked by kainate in rat organotypic spinal cord cultures.
Bajrektarevic D; Nistri A
Neurotoxicology; 2017 May; 60():34-41. PubMed ID: 28257918
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone modulates uptake activity of glial glutamate transporter-1 against global brain ischemia in rats.
Hu YY; Xu J; Zhang M; Wang D; Li L; Li WB
J Neurochem; 2015 Jan; 132(2):194-205. PubMed ID: 25270764
[TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice.
Fan S; Xian X; Li L; Yao X; Hu Y; Zhang M; Li W
J Alzheimers Dis; 2018; 66(4):1731-1743. PubMed ID: 30452416
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective potential of ceftriaxone in in vitro models of stroke.
Lipski J; Wan CK; Bai JZ; Pi R; Li D; Donnelly D
Neuroscience; 2007 May; 146(2):617-29. PubMed ID: 17363173
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological upregulation of GLT-1 alleviates the cognitive impairments in the animal model of temporal lobe epilepsy.
Ramandi D; Elahdadi Salmani M; Moghimi A; Lashkarbolouki T; Fereidoni M
PLoS One; 2021; 16(1):e0246068. PubMed ID: 33507976
[TBL] [Abstract][Full Text] [Related]
12. Activation of Glutamate Transporter-1 (GLT-1) Confers Sex-Dependent Neuroprotection in Brain Ischemia.
Tejeda-Bayron FA; Rivera-Aponte DE; Malpica-Nieves CJ; Maldonado-Martínez G; Maldonado HM; Skatchkov SN; Eaton MJ
Brain Sci; 2021 Jan; 11(1):. PubMed ID: 33429955
[TBL] [Abstract][Full Text] [Related]
13. Changes in the glutamate biomarker expression in rats vulnerable or resistant to the rewarding effects of cocaine and their reversal by ceftriaxone.
Niedzielska-Andres E; Mizera J; Sadakierska-Chudy A; Pomierny-Chamioło L; Filip M
Behav Brain Res; 2019 Sep; 370():111945. PubMed ID: 31100299
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury.
Verma R; Mishra V; Sasmal D; Raghubir R
Eur J Pharmacol; 2010 Jul; 638(1-3):65-71. PubMed ID: 20423712
[TBL] [Abstract][Full Text] [Related]
15. Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease.
Smaga I; Fierro D; Mesa J; Filip M; Knackstedt LA
Neurosci Biobehav Rev; 2020 Aug; 115():116-130. PubMed ID: 32485268
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.
Zumkehr J; Rodriguez-Ortiz CJ; Cheng D; Kieu Z; Wai T; Hawkins C; Kilian J; Lim SL; Medeiros R; Kitazawa M
Neurobiol Aging; 2015 Jul; 36(7):2260-2271. PubMed ID: 25964214
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability.
Nicholson KJ; Gilliland TM; Winkelstein BA
J Neurosci Res; 2014 Jan; 92(1):116-29. PubMed ID: 24123246
[TBL] [Abstract][Full Text] [Related]
18. Loss of the glutamate transporter splice-variant GLT-1b in inferior colliculus and its prevention by ceftriaxone in thiamine deficiency.
Jhala SS; Wang D; Hazell AS
Neurochem Int; 2011 Apr; 58(5):558-63. PubMed ID: 21256174
[TBL] [Abstract][Full Text] [Related]
19. Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats.
Das SC; Yamamoto BK; Hristov AM; Sari Y
Neuropharmacology; 2015 Oct; 97():67-74. PubMed ID: 26002627
[TBL] [Abstract][Full Text] [Related]
20. Current approaches to enhance glutamate transporter function and expression.
Fontana AC
J Neurochem; 2015 Sep; 134(6):982-1007. PubMed ID: 26096891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
